Accuray (ARAY) Cost of Revenue (2010 - 2026)
Accuray's (ARAY) quarterly Cost of Revenue came in at $79.6 million in Q1 2026, down 64.32% year-on-year from $223.0 million in Q1 2025, and up 1.77% quarter-over-quarter from $78.2 million in Q4 2025.
Accuray (ARAY) Cost of Revenue (2010 - 2026) Analysis & Trends
Accuray's Cost of Revenue history runs 17 years deep, the most recent figure standing at $79.6 million for Q1 2026.
- On a quarterly basis, Cost of Revenue fell 64.32% year-over-year to $79.6 million in Q1 2026; TTM through Mar 2026 was $239.3 million, a 37.24% decrease from a year earlier, with the FY2025 full-year figure at $311.5 million, up 2.6% from the prior year.
- Cost of Revenue improved to $79.6 million in Q1 2026 per ARAY's latest filing, from $78.2 million in the prior quarter.
- Across five years, Cost of Revenue topped out at $223.0 million in Q1 2025 and bottomed at $14.2 million in Q2 2025.
- The 5-year median for Cost of Revenue is $71.3 million (2023), against an average of $91.9 million.
- Across the five-year window, Cost of Revenue surged 315.54% in 2022 and slumped 64.32% in 2026, its largest moves.
- Year by year, Cost of Revenue stood at $71.8 million in 2022, then slipped by 0.64% to $71.3 million in 2023, then gained by 4.13% to $74.3 million in 2024, then advanced by 5.23% to $78.2 million in 2025, then advanced by 1.77% to $79.6 million in 2026.
- Per Business Quant, the three latest ARAY Cost of Revenue figures stand at $79.6 million (Q1 2026), $78.2 million (Q4 2025), and $67.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 4.89 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 2.21 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 3.40 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 12.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 362.60 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 441.60 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 481.00 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 2.51 Bn |
| 10 | Accuray | 27,968.40 | -38.51 Mn | 25.29 Mn | 79.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 79.55 Mn |
| Mar 31, 2026 | 79.55 Mn |
| Dec 31, 2025 | 78.17 Mn |
| Dec 31, 2025 | 78.17 Mn |
| Sep 30, 2025 | 67.39 Mn |
| Sep 30, 2025 | 67.39 Mn |
| Jun 30, 2025 | 14.21 Mn |
| Jun 30, 2025 | 14.21 Mn |
| Mar 31, 2025 | 222.97 Mn |
| Mar 31, 2025 | 222.97 Mn |
| Dec 31, 2024 | 74.28 Mn |
| Dec 31, 2024 | 74.28 Mn |
| Sep 30, 2024 | 67.08 Mn |
| Sep 30, 2024 | 67.08 Mn |
| Jun 30, 2024 | 16.98 Mn |
| Jun 30, 2024 | 16.98 Mn |
| Mar 31, 2024 | 207.79 Mn |
| Mar 31, 2024 | 207.79 Mn |
| Dec 31, 2023 | 71.34 Mn |
| Dec 31, 2023 | 71.34 Mn |